4/A: Pulmonx Corp Executive Lehman Amends SEC Filing to Correct Stock Option and RSU Details

David Aaron Lehman, General Counsel of Pulmonx Corp, files an amendment to a previous SEC Form 4 to correct errors in the reported number of shares related to employee stock options and restricted stock units.

Summary

• David Aaron Lehman, General Counsel of Pulmonx Corp, filed an amended Form 4 with the SEC on March 7, 2024.
• This amendment corrects errors in the original Form 4 filed on March 5, 2024, regarding the number of shares underlying an Employee Stock Option and Restricted Stock Units (RSUs).
• The corrected filing shows that on March 1, 2024, Lehman was granted 69,100 RSUs that vest quarterly over four years.
• Lehman was also granted an option to purchase 34,500 shares of common stock at an exercise price of $9.30, vesting monthly over 48 months, also beginning on March 1, 2024.
• Following these transactions, Lehman beneficially owns 214,588 shares of Pulmonx Corp.

Sentiment

Score: 7

Explanation: The sentiment is neutral. It's a routine correction of an SEC filing, indicating standard corporate governance procedures. The amendment itself doesn't suggest any positive or negative implications for the company's performance.

Positives

• The filing provides transparency into executive compensation and equity ownership at Pulmonx Corp.
• The correction of the filing demonstrates attention to detail and compliance with SEC regulations.

Negatives

• The need for an amendment suggests an initial oversight in the original filing.

Risks

• Inaccurate reporting of executive compensation can lead to regulatory scrutiny and reputational damage.

Industry Context

SEC filings are a routine part of corporate governance, providing transparency into insider transactions. Amendments are not uncommon and can occur for various reasons, including correcting errors or omissions.

Stakeholder Impact

• The corrected filing ensures accurate information is available to shareholders and potential investors.

Key Dates